Introduction Inflammatory bowel disease often affects women during their reproductive
years, causing management concerns for obstetricians caring for these patients during …

The safety of drug therapy for inflammatory bowel disease during pregnancy is an important
clinical concern. Current available information is largely derived from animal studies and …

Inflammatory bowel disease is relatively frequent in women of childbearing age. Disease
management requires greater attention during this clinical condition because of potential …

Inflammatory bowel diseases (IBD) have a high prevalence in younger patients with child-
bearing potential. Usually, pregnancies in women with IBD will develop normally, if the …

Abstract Background and Aims: Inflammatory bowel disease (IBD) is a chronic disease
affecting mainly young people in their reproductive years. IBD therefore has a major impact …

Women with Crohn disease appear to be at risk for early delivery and low birthweight
infants, and women with ulcerative colitis may be at increased risk for giving birth to children …

Drug therapy is justified in pregnant patients with active inflammatory bowel disease.
Selection of medical treatment depends on disease severity and the potential for fetal …

Crohn's disease commonly affects women of childbearing age. Available data on Crohn's
disease and pregnancy show that women with Crohn's disease can expect to conceive …

Aim: To study the effects of infliximab on pregnancy and foetal outcome. Methods: We
conducted a retrospective chart review of women with Crohn's disease treated intentionally …

Inflammatory bowel disease (IBD) has a peak age of onset in the 3rd decade and a peak
prevalent age in the fourth decade in most studies. As a result many patients affected by …